Benzinga | Oct 11, 2021 04:02PM EDT

Exscientia Announces Publication of EXALT-1 Trial In Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform To Improve Cancer Treatment Outcomes

Study shows benefit of the first AI-supported functional precision medicine platform to guide treatment selection and improve outcomes in patients with advanced haematological cancers

54% of patients demonstrated a clinical benefit of more than 1.3-fold enhanced progression-free survival compared to previous therapy

40% of patients experienced exceptional responses lasting at least three times longer than expected for their respective disease